A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2002
11/13/2002	EP1140916B1 Heteroaryl-cyclic acetals
11/13/2002	EP1102762B1 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
11/13/2002	EP1086092B1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE
11/13/2002	EP0891378B1 Use of a pharmaceutical composition comprising an appetite-suppressing peptide
11/13/2002	EP0748320B1 Prodrugs of morpholine tachykinin receptor antagonists
11/13/2002	CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002	CN1379816A Human G-protein coupled receptor
11/13/2002	CN1379814A Embryonic or stem-like cell lines produced by cross species nuclear transpcantation and methods for enhancing mebryonic development by genetic alteration of donor cells or by tissue culture conditions
11/13/2002	CN1379776A Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation
11/13/2002	CN1379774A Compounds
11/13/2002	CN1379772A Substituted indoles for modulating NFKB activity
11/13/2002	CN1379766A Benzoic acid derivatives for treatment of diabetes mellitus
11/13/2002	CN1379765A Benzodiazepine derivatives usable as parental metabolic glutamate receptor antagonist
11/13/2002	CN1379764A Benzodiazepine derivatives
11/13/2002	CN1379761A Condensed indoline derivatives and their use as 5HT, in particular 5HT2C receptor ligands
11/13/2002	CN1379756A Substituted nor bornylamino derivatives, method for production thereof, use thereof as medicament or diagnostic reagent medicaments containing said compounds
11/13/2002	CN1379752A Aromatic di-ceto-derivatives use as glucose-6-phosphate translocase inhibitors
11/13/2002	CN1379675A 24-hydroxyvitamin D, analogs and use thereof
11/13/2002	CN1379672A Highly selective norepinephrine reuptake inhibitors and methods of using same
11/13/2002	CN1379669A Valdecoxib compositions
11/13/2002	CN1379149A Weight-lossing fabric and its preparing process
11/13/2002	CN1379082A Solid culture method of antrodia camphorate, its cultured solid substance, and its product and application
11/13/2002	CN1378863A Active casein phosphopeptide and its preparing process
11/13/2002	CN1378847A 鲨鱼软骨胶囊 Shark Cartilage Capsules
11/13/2002	CN1378846A Shark-liver oil softgel
11/13/2002	CN1378845A Ursine seal penis capsule
11/13/2002	CN1378844A Ursine seal tablet for making bone robust
11/13/2002	CN1378839A 'Runlizi' tablet
11/13/2002	CN1378836A Exterior-applied article for losing weight
11/13/2002	CN1094152C 光合细菌的应用及利用它制得的产品 Application of photosynthetic bacteria and use it to obtain the product
11/13/2002	CN1094042C Tea water cooling and refreshing function
11/12/2002	US6479676 OxiranEcarboxylic acids for the treatment of diabetes
11/12/2002	US6479548 Substituted stilbenes as glucose uptake enhancers
11/12/2002	US6479544 Therapeutic combinations of fatty acids
11/12/2002	US6479538 Cyclic ether vitamin D3 compounds, 1α(OH)3-EPI-vitamin D3 compounds and uses thereof
11/12/2002	US6479534 Indoline derivatives and method of treating obesity
11/12/2002	US6479507 Modulation of these inflammatory cytokines is considered one of the most effective strategies to block chronic inflammation and have positive therapeutic outcomes
11/12/2002	US6479503 Cycloalkano-indole and -azaindole derivatives
11/12/2002	US6479502 Hydroxamic acid derivatives as proteinase inhibitors
11/12/2002	US6479500 Alleviating side effects caused by use of an anti-tumor agent comprising administering 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1h,3h)-pyrimidin edione
11/12/2002	US6479497 Compounds having a selective effect at a subgroup of 5-hydroxytryptamine receptors, designated the h5-ht1b receptor
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	US6479490 Treatment of diseases characterized by excess th2 cytokines and/ or an excess ige production.
11/12/2002	US6479479 Azetidine derivatives, their preparation and pharmaceutical compositions containing them
11/12/2002	US6479470 Naag and naaladase have been implicated in several pathological conditions relating to glutamate abnormalities and neurotoxicity
11/12/2002	US6479270 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
11/12/2002	US6479050 Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof
11/12/2002	CA2271781C Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
11/12/2002	CA2059558C Use of calcium antagonists for treating scars
11/12/2002	CA2055948C Use of a combination of angiotensin-converting enzyme inhibitor and calcium antagonist for the treatment of proteinuria
11/11/2002	CA2385692A1 Thiazole derivatives
11/11/2002	CA2347879A1 Substituted dicinnamoylquinides and their use in augmentation of adenosine function
11/07/2002	WO2002088356A1 Novel g protein-coupled receptor protein and dna thereof
11/07/2002	WO2002088354A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002	WO2002088317A2 Fusion molecules and methods for treatment of immune diseases
11/07/2002	WO2002088316A2 G-protein coupled receptors
11/07/2002	WO2002088286A1 Sterol compositions, fat compositions containing the same and foods
11/07/2002	WO2002088182A1 Nove g protein-coupled receptor protein and dna thereof
11/07/2002	WO2002088159A1 Pharmaceutically active uridine esters
11/07/2002	WO2002088157A1 N-substituted pyrazolyl-o-glycoside derivatives and remedial agent for diabetes containing the same
11/07/2002	WO2002088146A2 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H-[1,4]DIOXINO[2,3-e]INDOLE
11/07/2002	WO2002088144A2 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO[2,3-f]QUINOXALINE
11/07/2002	WO2002088143A2 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
11/07/2002	WO2002088140A1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
11/07/2002	WO2002088139A1 6h-oxazolo[4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
11/07/2002	WO2002088138A1 Novel 4-amino-5,6-substituted thiopheno[2,3-d]pyrimidines
11/07/2002	WO2002088137A1 Pkb-3564 substance with neovascularization inhibitory activity
11/07/2002	WO2002088135A1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans
11/07/2002	WO2002088131A1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta[a]naphthalene
11/07/2002	WO2002088121A1 Pyrazolo[1,5-a]pyridines and medicines containing the same
11/07/2002	WO2002088118A1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
11/07/2002	WO2002088115A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
11/07/2002	WO2002088110A1 Quinoline derivative having azolyl group and quinazoline derivative
11/07/2002	WO2002088107A1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
11/07/2002	WO2002088097A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	WO2002088090A2 Pyrazole derived kinase inhibitors
11/07/2002	WO2002088089A1 Spiropiperidine derivatives, nociceptin receptor antagonists containing the same as the active ingredient and medicinal compositions
11/07/2002	WO2002088084A1 Heterocyclic compound derivatives and medicines
11/07/2002	WO2002088080A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088079A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088078A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES
11/07/2002	WO2002087626A1 Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same
11/07/2002	WO2002087603A1 Immunopotentiators
11/07/2002	WO2002087598A1 Improvements in and relating to the administration of copper to an animal
11/07/2002	WO2002087597A1 Oral delivery of macromolecules
11/07/2002	WO2002087593A1 A method for treating or preventing a functional vitamin b12 deficiency in an individual and to medical compositions for use in said method
11/07/2002	WO2002087584A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/07/2002	WO2002087580A1 Abc expression promoters
11/07/2002	WO2002087567A2 Polymethoxylated flavones for treating insulin resistance
11/07/2002	WO2002087566A1 The use of enantiomeric pure escitalopram
11/07/2002	WO2002087562A1 Use of protein and essential amino acids to treat amenorrhea and related disorders
11/07/2002	WO2002087556A2 Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality
11/07/2002	WO2002087555A2 Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer
11/07/2002	WO2002087513A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002	WO2002087510A2 Subcellular targeting of therapeutic proteins
11/07/2002	WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002	WO2002056708A3 Preparation for improved dietary utilisation
11/07/2002	WO2002044141A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
11/07/2002	WO2001085687A1 Substituted indoles as parp inhibitors

1 ... 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 ... 1298